• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX (TRIVASCULAR) OVATION IX; ILIAC LIMB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX (TRIVASCULAR) OVATION IX; ILIAC LIMB Back to Search Results
Model Number TV-IL1418140-J
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Occlusion (1984)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The lot history records related to the subject device referenced in this complaint record were reviewed for potential contributing factors for the failure mode(s) described in this event.A review of the device quality records showed that the device(s) demonstrated compliance to established procedures and specifications at the time of manufacture.
 
Event or Problem Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with the ovation ix abdominal stent graft system.Approximately two (2) years post initial procedure, a limb occlusion was identified on unknown date.The patient was treated; lysed and relined with vbx (non-endologix) on an unknown date and reported as doing well.
 
Additional Manufacturer Narrative
Clinical assessment was completed based on the received medical records.The reported total occlusion of both ovation stents just below the renal arteries was confirmed.Device, user, procedure or anatomy relatedness of this event could not be determined.The procedure related harm identified was a prolonged hospitalization following the secondary endovascular procedure.Additionally, it was reported the patient had a previous thoracic aneurysm repair prior to the index evar procedure (cautionary product use condition).The final patient status was discharged on the ninth post-operative day to a rehabilitation unit due to a debilitated state.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device remains implanted; therefore, no device evaluation was completed.No additional investigation of this reported event is planned; however, if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Common Device Name
ILIAC LIMB
Manufacturer (Section D)
ENDOLOGIX (TRIVASCULAR)
3910 brickway blvd
santa rosa CA 95403
MDR Report Key9119187
Report Number3008011247-2019-00147
Device Sequence Number2113197
Product Code MIH
UDI-Device IdentifierM701TVIL1418140J1
UDI-Public+M701TVIL1418140J1/$$3200105FS08051610F
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/31/2020
Device Model NumberTV-IL1418140-J
Device Catalogue NumberTV-IL1418140-J
Device Lot NumberFS080516-10
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 08/27/2019
Supplement Date Received by Manufacturer08/27/2019
Initial Report FDA Received Date09/25/2019
Supplement Report FDA Received Date08/05/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
OVATION CUSTOM SEAL FILL POLYMER.; OVATION IX AORTIC MAIN BODY.; OVATION IX ILIAC LIMB.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age65 YR
-
-